These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae. Ng TM, Khong WX, Harris PN, De PP, Chow A, Tambyah PA, Lye DC. PLoS One; 2016; 11(4):e0153696. PubMed ID: 27104951 [Abstract] [Full Text] [Related]
3. Raoultella planticola bacteraemia. Hu AY, Leslie KA, Baskette J, Elsayed S. J Med Microbiol; 2012 Oct; 61(Pt 10):1488-1489. PubMed ID: 22820690 [No Abstract] [Full Text] [Related]
4. Discitis due to Clostridium perfringens. Caudron A, Grados F, Boubrit Y, Coullet JM, Merrien D, Domart Y. Joint Bone Spine; 2008 Mar; 75(2):232-4. PubMed ID: 17977774 [Abstract] [Full Text] [Related]
5. Clinical and Economic Impact of Empirical Extended-Infusion Piperacillin-Tazobactam in a Community Medical Center. Brunetti L, Poustchi S, Cunningham D, Toscani M, Nguyen J, Lim J, Ding Y, Nahass RG. Ann Pharmacother; 2015 Jul; 49(7):754-60. PubMed ID: 25855703 [Abstract] [Full Text] [Related]
6. A case of Robinsoniella peoriensis bacteremia during using piperacillin-tazobactam. Furuya K, Ito K, Sugiyama K, Makio S, Shimada T. J Infect Chemother; 2023 Sep; 29(9):913-915. PubMed ID: 37263500 [Abstract] [Full Text] [Related]
7. Vancomycin-resistant Clostridium innocuum bacteremia following oral vancomycin for Clostridium difficile infection. Hung YP, Lin HJ, Wu CJ, Chen PL, Lee JC, Liu HC, Wu YH, Yeh FH, Tsai PJ, Ko WC. Anaerobe; 2014 Dec; 30():24-6. PubMed ID: 25102472 [Abstract] [Full Text] [Related]
8. Decubitus ulcer infection and bacteremia due to tazobactam/piperacillin-resistant Veillonella parvula. Sahara S, Kinoshita T, Amano T, Ishida M, Yamakita T, Takimoto N, Oka K. Nagoya J Med Sci; 2024 Aug; 86(3):524-530. PubMed ID: 39355367 [Abstract] [Full Text] [Related]
9. Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC project. Delgado-Valverde M, Torres E, Valiente-Mendez A, Almirante B, Gómez-Zorrilla S, Borrell N, Corzo JE, Gurgui M, Almela M, García-Álvarez L, Fontecoba-Sánchez MC, Martínez-Martínez L, Cantón R, Praena J, Causse M, Gutiérrez-Gutiérrez B, Roberts JA, Farkas A, Pascual Á, Rodríguez-Baño J, REIPI/GEIH-SEIMC BACTERAEMIA-MIC Group. J Antimicrob Chemother; 2016 Feb; 71(2):521-30. PubMed ID: 26538507 [Abstract] [Full Text] [Related]
10. Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint. Tam VH, Gamez EA, Weston JS, Gerard LN, Larocco MT, Caeiro JP, Gentry LO, Garey KW. Clin Infect Dis; 2008 Mar 15; 46(6):862-7. PubMed ID: 18279040 [Abstract] [Full Text] [Related]
11. Liver abscess caused by multidrug-resistant Pseudomonas aeruginosa treated with colistin; a case report and review of the literature. Yaita K, Sameshima I, Takeyama H, Matsuyama S, Nagahara C, Hashiguchi R, Moronaga Y, Tottori N, Komatsu M, Oshiro Y, Yamaguchi Y. Intern Med; 2013 Mar 15; 52(12):1407-12. PubMed ID: 23774557 [Abstract] [Full Text] [Related]
12. Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum β-lactamase-producing Proteus mirabilis. Tsai HY, Chen YH, Tang HJ, Huang CC, Liao CH, Chu FY, Chuang YC, Sheng WH, Ko WC, Hsueh PR. Diagn Microbiol Infect Dis; 2014 Nov 15; 80(3):222-6. PubMed ID: 25139843 [Abstract] [Full Text] [Related]
13. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial. Harris PNA, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M, Alenazi TH, Arabi Y, Falcone M, Bassetti M, Righi E, Rogers BA, Kanj S, Bhally H, Iredell J, Mendelson M, Boyles TH, Looke D, Miyakis S, Walls G, Al Khamis M, Zikri A, Crowe A, Ingram P, Daneman N, Griffin P, Athan E, Lorenc P, Baker P, Roberts L, Beatson SA, Peleg AY, Harris-Brown T, Paterson DL, MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN). JAMA; 2018 Sep 11; 320(10):984-994. PubMed ID: 30208454 [Abstract] [Full Text] [Related]
14. A 64-Year-Old Man with Low Back Pain Due to Clostridium perfringens Lumbar Discitis. Bhatt H, Singh S. Am J Case Rep; 2021 Jan 22; 22():e928014. PubMed ID: 33479190 [Abstract] [Full Text] [Related]
15. The Effect of a Piperacillin/Tazobactam Shortage on Antimicrobial Prescribing and Clostridium difficile Risk in 88 US Medical Centers. Gross AE, Johannes RS, Gupta V, Tabak YP, Srinivasan A, Bleasdale SC. Clin Infect Dis; 2017 Aug 15; 65(4):613-618. PubMed ID: 28444166 [Abstract] [Full Text] [Related]
16. Effect of antimicrobial therapy on mortality in 377 episodes of Enterobacter spp. bacteraemia. Marcos M, Iñurrieta A, Soriano A, Martínez JA, Almela M, Marco F, Mensa J. J Antimicrob Chemother; 2008 Aug 15; 62(2):397-403. PubMed ID: 18420813 [Abstract] [Full Text] [Related]
17. Lumbar discitis caused by Clostridium perfringens. Lotte R, Popoff MR, Degand N, Lotte L, Bouvet P, Baudin G, Cua E, Roger PM, Ruimy R. J Clin Microbiol; 2014 Oct 15; 52(10):3813-5. PubMed ID: 25056327 [Abstract] [Full Text] [Related]
18. Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial. Harris PN, Peleg AY, Iredell J, Ingram PR, Miyakis S, Stewardson AJ, Rogers BA, McBryde ES, Roberts JA, Lipman J, Athan E, Paul SK, Baker P, Harris-Brown T, Paterson DL. Trials; 2015 Jan 27; 16():24. PubMed ID: 25623485 [Abstract] [Full Text] [Related]
19. Rahnella aquatilis bacteremia in a patient with relapsed acute lymphoblastic leukemia. Carinder JE, Chua JD, Corales RB, Taege AJ, Procop GW. Scand J Infect Dis; 2001 Jan 27; 33(6):471-3. PubMed ID: 11450870 [Abstract] [Full Text] [Related]
20. Piperacillin/tazobactam-induced paresthesiae. Lambourne J, Kitchen J, Hughes C, Merry C. Ann Pharmacother; 2006 May 27; 40(5):977-9. PubMed ID: 16622157 [Abstract] [Full Text] [Related] Page: [Next] [New Search]